ETI Karle Clinical, based in India, will conduct Oramed Pharmaceuticals Phase IIb trials on its oral insulin capsules in diabetic type 2 patients.

It is anticipated that the Phase IIb study will enroll 60 subjects and begin in the first quarter of 2009.

This site uses Akismet to reduce spam. Learn how your comment data is processed.